Accordingly, the publishers and the ISN, the editorial board and their respective employers, office and agents accept no liability whatsoever for the consequences of any such inaccurate or misleading data, opinion or statement. While every effort is made to ensure that drug doses and other quantities are presented accurately, readers are advised that new methods and techniques involving drug usage, and described within this Journal, should only be followed in conjunction with the drug manufacturer s own published literature. chapter 6 http://www.kidney-international.org & 2013 KDIGO Methods for guideline development AIM The overall aim of this project was to develop an evidence- based CPG for the management of dyslipidemia and CKD. The guideline consists of recommendation statements, ratio- nales, and a summary of systematically generated evidence on relevant pre-defined clinical topics. The general guideline development method is described at http://www.kdigo.org/ home/guidelines/development as well as below. 